Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Nishiura, Hiroshi ^a,b,c   Kamiya, Kazuko ^d  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Narita Airport Quarantine Station   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; AZITHROMYCIN; CEFCAPENE PIVOXIL; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; AIRPORT; ARTICLE; AXILLA TEMPERATURE; BODY TEMPERATURE; BODY TEMPERATURE MEASUREMENT; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; HYPERTHERMIA; INTERMETHOD COMPARISON; JAPAN; MALE; MASS SCREENING; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SCHOOL CHILD; SELF REPORT; SENSITIVITY AND SPECIFICITY; SURFACE TEMPERATURE; THERMOGRAPHY; ADOLESCENT; AVIATION; COMPARATIVE STUDY; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PANDEMIC; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TRAVEL; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIRPORTS; AVIATION; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PANDEMICS; RETROSPECTIVE STUDIES; THERMOGRAPHY; TRAVEL; YOUNG ADULT;

EID: 79955515372     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-111     Document Type: Article

References (46)

1. Bell DM, . World Health Organization Working Group on International and Community Transmission of SARS Public health interventions and SARS spread, 2003. Emerg Infect Dis 2004, 10:1900-6. World Health Organization Working Group on International and Community Transmission of SARS.
2. St John RK, King A, de Jong D, Bodie-Collins M, Squires SG, Tam TW. Border screening for SARS. Emerg Infect Dis 2005, 11:6-10.
3. Bell DM, . World Health Organization Writing Group Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006, 12:81-7. World Health Organization Writing Group.
4. McLeod MA, Baker M, Wilson N, Kelly H, Kiedrzynski T, Kool JL. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic. Emerg Infect Dis 2008, 14:468-70. 10.3201/eid1403.070927, 2570822, 18325264.
5. Pitman RJ, Cooper BS, Trotter CL, Gay NJ, Edmunds WJ. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ 2005, 331:1242-3. 1289321, 16308384.
6. Glass K, Becker NG. Evaluation of measures to reduce international spread of SARS. Epidemiol Infect 2006, 134:1092-101. 10.1017/S0950268806005863, 2870475, 16476169.
7. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epdiemiol 2008, 167:775-85.
8. Nishiura H, Wilson N, Baker MG. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infect Dis 2009, 9:27. 10.1186/1471-2334-9-27, 2670846, 19284571.
9. Inaba H, Nishiura H. The state-reproduction number for a multistate class age structured epidemic system and its application to the asymptomatic transmission model. Math Biosci 2008, 216:77-89. 10.1016/j.mbs.2008.08.005, 18768142.
10. Cowling BJ, Lau LL, Wu P, Wong HW, Fang VJ, Riley S, Nishiura H. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis 2010, 10:82. 10.1186/1471-2334-10-82, 20353566.
11. Governmental Committee of Action Plans against Influenza Pandemic Action Plans against Influenza Pandemic 2009, Tokyo, The Government of Japan, in Japanese [last accessed on 16 November 2010], Governmental Committee of Action Plans against Influenza Pandemic., http://www.cas.go.jp/jp/seisaku/ful/kettei/071026keikaku.pdf
12. Chan LS, Cheung GT, Lauder IJ, Kumana CR, Lauder IJ. Screening for fever by remote-sensing infrared thermographic camera. J Travel Med 2004, 11:273-9.
13. Hughes WT, Patterson GG, Thornton D, Williams BJ, Lott L, Dodge R. Detection of fever with infrared thermometry: a feasibility study. J Infect Dis 1985, 152:301-6. 10.1093/infdis/152.2.301, 4031545.
14. McBride WJ, Buikstra E, FitzGerald M. Investigation of febrile passengers detected by infrared thermal scanning at an international airport. Aust NZ J Public Health 2010, 34:5-10.
15. Ng EY, Kaw GJ, Chang WM. Analysis of IR thermal imager for mass blind fever screening. Microvasc Res 2004, 68:104-9. 10.1016/j.mvr.2004.05.003, 15313119.
16. Ng EY. Is thermal scanner losing its bite in mass screening of fever due to SARS?. Med Phys 2005, 32:93-7. 10.1118/1.1819532, 15719959.
17. Ng DK, Chan CH, Lee RS, Leung LC. Non-contact infrared thermometry temperature measurement for screening fever in children. Ann Trop Paediatr 2005, 25:267-75. 10.1179/146532805X72412, 16297301.
18. Chiu WT, Lin PW, Chiou HY, Lee WS, Lee CN, Yang YY, Lee HM, Hsieh MS, Hu CJ, Ho YS, Deng WP, Hsu CY. Infrared thermography to mass-screen suspected SARS patients with fever. Asia Pac J Public Health 2005, 17:26-8. 10.1177/101053950501700107, 16044829.
19. Liu CC, Chang RE, Change WC. Limitations of forehead infrared body temperature detection for fever screening for severe acute respiratory syndrome. Infect Control Hosp Epidemiol 2004, 25:1109-11. 10.1086/502351, 15636300.
20. Bitar D, Goubar A, Desenclos JC. International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of non-contact infrared thermometers. Euro Surveill 2009, 14:pii19115.
21. Hausfater P, Zhao Y, Defrenne S, Bonnet P, Riou B. Cutaneous infrared thermometry for detecting febrile patients. Emerg Infect Dis 2008, 14:1255-8. 2600390, 18680649.
22. Suzuki T, Wada K, Wada Y, Kagitani H, Arioka T, Maeda K, Kida K. The validity of mass body temperature screening with ear thermometers in a warm thermal environment. Tohoku J Exp Med 2010, 222:89-95. 10.1620/tjem.222.89, 20877164.
23. Shimada T, Gu Y, Kamiya H, Komiya N, Odaira F, Sunagawa T, Takahashi H, Toyokawa T, Tsuchihashi Y, Yasui Y, Tada Y, Okabe N. Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill 2009, 14:pii = 19244.
24. Department of Quarantine, Narita Airport Quarantine Station Report of responses to pandemic influenza at the Narita Airport Quarantine Station 2009, Chiba, Narita Airport Quarantine Station, in Japanese [last accessed on 16 Novmber 2010], Department of Quarantine, Narita Airport Quarantine Station., http://www.forth.go.jp/keneki/narita/pdf/20090805_NQ_H1N1%20flu_Report.pdf
25. Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med 2007, 26:2170-83. 10.1002/sim.2677, 16927452.
26. Gengsheng Q, Hotilovac L. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test. Stat Methods Med Res 2008, 17:207-21.
27. Nguyen AV, Cohen NJ, Lipman H, Brown CM, Molinari NA, Jackson WL, Kirking H, Szymanowski P, Wilson TW, Salhi BA, Roberts RR, Stryker DW, Fishbein DB. Comparison of 3 infrared thermal detection systems and self-report for mass fever screening. Emerg Infect Dis 2010, 16:1710-7.
28. Nishiura H. Joint quantification of transmission dynamics and diagnostic accuracy applied to influenza. Math Biosc Eng 2011, 8:49-64.
29. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza?. JAMA 2005, 293:987-97. 10.1001/jama.293.8.987, 15728170.
30. Nishiura H. Real-time forecasting of an epidemic using a discrete time stochastic model: a case study of pandemic influenza (H1N1-2009). Biomed Eng Online 2011, 10:15. 10.1186/1475-925X-10-15, 3045989, 21324153.
31. Kasper MR, Wierzba TF, Sovann L, Blair PJ, Putnam SD. Evaluation of an influenza-like illness case definition in the diagnosis of influenza among patients with acute febrile illness in Cambodia. BMC Infect Dis 2010, 10:320. 10.1186/1471-2334-10-320, 2988054, 21054897.
32. Thursky K, Cordova SP, Smith D, Kelly H. Working towards a simple case definition for influenza surveillance. J Clin Virol 2003, 27:170-9. 10.1016/S1386-6532(02)00172-5, 12829039.
33. Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006, 27:266-70. 10.1086/501539, 16532414.
34. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-15. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team.
35. Priest PC, Duncan AR, Jennings LC, Baker MG. Thermal image scanning for influenza border screening: Results of an airport screening study. PLoS One 2011, 6:e14490. 10.1371/journal.pone.0014490, 3016318, 21245928.
36. Andersson SE, Edvinsson ML, Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci 2003, 105:699-707. 10.1042/CS20030037, 12848618.
37. Nishiura H. Travel and age of influenza A (H1N1) 2009 virus infection. J Travel Med 2010, 17:269-70.
38. Reichert T, Chowell G, Nishiura H, Christensen RA, McCullers JA. Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?. BMC Infect Dis 2010, 10:5. 10.1186/1471-2334-10-5, 3003248, 20059763.
39. Wada K, Nishiura H, Kawana A. An epidemiological analysis of severe cases of the influenza A (H1N1) 2009 virus infection in Japan. Influenza Other Respi Viruses 2010, 4:179-86. 10.1111/j.1750-2659.2010.00143.x, 20836793.
40. Nishiura H, Cook AR, Cowling BJ. Assortativity and the probability of epidemic extinction: A case study of pandemic influenza A (H1N1-2009). Interdiscip Perspect Infect Dis 2011, 2011:194507. 3017939, 21234337., http://www.hindawi.com/journals/ipid/2011/194507.html
41. Nishiura H, Chowell G, Castillo-Chavez C. Did modeling overestimate the transmission potential of pandemic (H1N1-2009)? Sample size estimation for post-epidemic seroepidemiological studies. PLoS One 2011, 6:e17908. 10.1371/journal.pone.0017908, 3063792, 21455307.
42. World Health Organization International Health Regulations (2005) 2005, Geneva, World Health Organization, [last accessed on 16 Novmber 2010], World Health Organization., http://www.who.int/ihr/en/
43. Nishiura H, Inaba H. Estimation of the incubation period of influenza A (H1N1-2009) among imported cases: Addressing censoring using outbreak data at the origin of importation. J Theor Biol 2011, 272:123-30. 10.1016/j.jtbi.2010.12.017, 21168422.
44. Matsui T, Hakozaki Y, Suzuki S, Usui T, Kato T, Hasegawa K, Sugiyama Y, Sugamata M, Abe S. A novel screening method for influenza patients using a newly developed non-contact screening system. J Infect 2010, 60:271-7. 10.1016/j.jinf.2010.01.005, 20138082.
45. Omori R, Nishiura H. Theoretical basis to measure the impact of short-lasting control of an infectious disease on the epidemic peak. Theor Biol Med Model 2011, 8:2. 10.1186/1742-4682-8-2, 3040699, 21269441.
46. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. Delaying the international spread of pandemic influenza. PLoS Med 2006, 3:e212. 10.1371/journal.pmed.0030212, 1450020, 16640458.